Octagon Capital Advisors’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$145K	–	33
2022 Q3	$145K	Buy	+30,000	New	+$145K	0.03%	35